|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
National Eye Institute (NEI) |
|---|---|
| Information provided by: | National Eye Institute (NEI) |
| ClinicalTrials.gov Identifier: | NCT00000141 |
Purpose
To test the efficacy, safety, and costs of providing supplemental oxygen in moderately severe retinopathy of prematurity (prethreshold ROP).
| Condition | Intervention | Phase |
|---|---|---|
|
Retinopathy of Prematurity |
Drug: Oxygen |
Phase III |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized |
Eligibility| Ages Eligible for Study: | up to 1 Year |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Newborns with prethreshold ROP in one or both eyes are eligible.
Contacts and Locations
Show 24 Study Locations
More Information
| Study ID Numbers: | NEI-40 |
| Study First Received: | September 23, 1999 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00000141 History of Changes |
| Health Authority: | United States: Federal Government |
|
Eye Diseases Infant, Newborn, Diseases Infant, Premature, Diseases Retinopathy of Prematurity Retinal Diseases |
|
Eye Diseases Infant, Newborn, Diseases Infant, Premature, Diseases Retinopathy of Prematurity Retinal Diseases |